{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:48:28Z","timestamp":1791229708658,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00415-019-09379-w","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:17:13Z","timestamp":1558505833000},"page":"2051-2059","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Myopathy and scleromyxedema"],"prefix":"10.1007","volume":"266","author":[{"given":"Antoine","family":"Soulages","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Marie-Ange","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pham-Ledard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"N\u00e9grier-Leibreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Cosnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Carla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendal","family":"Le Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0775-4625","authenticated-orcid":false,"given":"St\u00e9phane","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"9379_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaad.2013.01.007","volume":"69","author":"F Rongioletti","year":"2013","unstructured":"Rongioletti F, Merlo G, Cinotti E, Fausti V, Cozzani E, Cribier B et al (2013) Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients. J Am Acad Dermatol 69:66\u201372","journal-title":"J Am Acad Dermatol"},{"key":"9379_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000251859","volume":"147","author":"BL Johnson","year":"1973","unstructured":"Johnson BL, Horowitz IR, Charles CR, Cooper DL (1973) Dermatomyositis and lichen myxedematosus. A clinical, histopathological and electron microscopic study. Dermatologica 147:109\u2013122","journal-title":"Dermatologica"},{"key":"9379_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2133.1975.tb06786.x","volume":"93","author":"R Kubba","year":"1975","unstructured":"Kubba R, Champion RH (1975) Scleromyxoedema. Br J Dermatol. 93:36\u201338","journal-title":"Br J Dermatol."},{"key":"9379_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/ajcp\/69.4.446","volume":"69","author":"MA Verity","year":"1978","unstructured":"Verity MA, Toop J, McAdam LP, Pearson CM (1978) Scleromyxedema myopathy. Histochemical and electron microscopic observations. Am J Clin Pathol 69:446\u2013451","journal-title":"Am J Clin Pathol"},{"key":"9379_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1001\/archderm.1979.04010030003002","volume":"115","author":"RB Harris","year":"1979","unstructured":"Harris RB, Perry HO, Kyle RA, Winkelmann RK (1979) Treatment of scleromyxedema with melphalan. Arch Dermatol 115:295\u2013299","journal-title":"Arch Dermatol"},{"key":"9379_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1445-5994.1986.tb01180.x","volume":"16","author":"JM Harvey","year":"1986","unstructured":"Harvey JM, Zilko PJ, Cheah PS, Mastaglia FL, Ojeda VJ (1986) Scleromyxedema and inflammatory myopathy: a clinicopathologic study of three patients. Aust N Z J Med 16:329\u2013335","journal-title":"Aust N Z J Med"},{"key":"9379_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/art.1780290716","volume":"29","author":"EJ Fudman","year":"1986","unstructured":"Fudman EJ, Golbus J, Ike RW (1986) Scleromyxedema with systemic involvement mimics rheumatic diseases. Arthritis Rheum 29:913\u2013917","journal-title":"Arthritis Rheum"},{"key":"9379_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/art.1780311115","volume":"31","author":"DJ Helfrich","year":"1988","unstructured":"Helfrich DJ, Walker ER, Martinez AJ, Medsger TA Jr (1988) Scleromyxedema myopathy: case report and review of the literature. Arthritis Rheum 31:1437\u20131441","journal-title":"Arthritis Rheum"},{"key":"9379_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1365-4362.1989.tb02437.x","volume":"28","author":"AO Harris","year":"1989","unstructured":"Harris AO, Altman AR, Tschen JA, Wolf JE Jr (1989) Scleromyxedema. Int J Dermatol 28:661\u2013667","journal-title":"Int J Dermatol"},{"key":"9379_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1365-4362.1989.tb02436.x","volume":"28","author":"MJ Rothe","year":"1989","unstructured":"Rothe MJ, Rivas R, Gould E, Kerdel FA (1989) Scleromyxedema and severe myositis. Int J Dermatol 28:657\u2013660","journal-title":"Int J Dermatol"},{"key":"9379_CR11","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/0190-9622(91)70132-L","volume":"24","author":"BM Hisler","year":"1991","unstructured":"Hisler BM, Savoy LB, Hashimoto K (1991) Improvement of scleromyxedema associated with isotretinoin therapy. J Am Acad Dermatol 24:854\u2013857","journal-title":"J Am Acad Dermatol"},{"key":"9379_CR12","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/rheumatology\/33.9.872","volume":"33","author":"AL Taylor","year":"1994","unstructured":"Taylor AL, Owen ET (1994) Scleromyxoedema associated with synovitis and myopathy. Br J Rheumatol 33:872\u2013874","journal-title":"Br J Rheumatol"},{"key":"9379_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0190-9622(99)70383-X","volume":"41","author":"Z Bata-Csorgo","year":"1999","unstructured":"Bata-Csorgo Z, Husz S, Foldes M, Korom I, Molnar K, Morvay M et al (1999) Scleromyxedema. J Am Acad Dermatol 41:343\u2013346","journal-title":"J Am Acad Dermatol"},{"key":"9379_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0025-6196(11)65128-8","volume":"74","author":"D Rayson","year":"1999","unstructured":"Rayson D, Lust JA, Duncan A, Su WP (1999) Scleromyxedema: a complete response to prednisone. Mayo Clin Proc 74:481\u2013484","journal-title":"Mayo Clin Proc"},{"key":"9379_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1067\/mjd.2000.104001","volume":"43","author":"RK Lister","year":"2000","unstructured":"Lister RK, Jolles S, Whittaker S, Black C, Forgacs I, Cramp M et al (2000) Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 43:403\u2013408","journal-title":"J Am Acad Dermatol"},{"key":"9379_CR16","first-page":"36","volume":"70","author":"PV Prasad","year":"2004","unstructured":"Prasad PV, Joseph JM, Kaviarasan PK, Viswanathan P (2004) Scleromyxedema with subclinical myositis. Indian J Dermatol Venereol Leprol 70:36\u201338","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"9379_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1468-3083.2008.02766.x","volume":"23","author":"MY Wu","year":"2009","unstructured":"Wu MY, Hong JB, Yang CC, Hu SL, Liao YH (2009) Scleromyxedema with myopathy was successfully treated by thalidomide. J Eur Acad Dermatol Venereol 23:189\u2013190","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9379_CR18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1365-2230.2010.03807.x","volume":"35","author":"E Tan","year":"2010","unstructured":"Tan E, Lau N, Yung A (2010) Scleromyxoedema: a cause for unexplained encephalopathy and myositis. Clin Exp Dermatol 35:746\u2013748","journal-title":"Clin Exp Dermatol"},{"key":"9379_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000356469","volume":"5","author":"M Dolenc-Voljc","year":"2013","unstructured":"Dolenc-Voljc M, Jurcic V, Hocevar A, Tomsic M (2013) Scleromyxedema with subcutaneous nodules: successful treatment with thalidomide and intravenous immunoglobulin. Case Rep Dermatol 5:309\u2013315","journal-title":"Case Rep Dermatol"},{"key":"9379_CR20","volume-title":"Rook\u2019s textbook of dermatology","author":"F Rongioletti","year":"2016","unstructured":"Rongioletti F (2016) Cutaneous mucinoses. In: Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D (eds) Rook\u2019s textbook of dermatology, 9th edn. Wiley, Oxford","edition":"9"},{"key":"9379_CR21","first-page":"569","volume":"37","author":"W Dubreuilh","year":"1906","unstructured":"Dubreuilh W (1906) Fibromes miliaires folliculaires; scl\u00e9rodermie cons\u00e9cutive. Ann Dermatol Syph 37:569\u2013572","journal-title":"Ann Dermatol Syph"},{"key":"9379_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/BF01949029","volume":"92","author":"K Reitman","year":"1908","unstructured":"Reitman K (1908) \u00dcber eine eigenartige, der Sklerodermie nahestehende Affektion. Arch Dermatol Syph 92:417\u2013424","journal-title":"Arch Dermatol Syph"},{"key":"9379_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/jid.1953.25","volume":"20","author":"H Montgomery","year":"1953","unstructured":"Montgomery H, Underwood LJ (1953) Lichen myxedematosus; differentiation from cutaneous myxedemas or mucoid states. J Invest Dermatol 20:213\u2013236","journal-title":"J Invest Dermatol"},{"key":"9379_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF00362184","volume":"199","author":"HA Gottron","year":"1954","unstructured":"Gottron HA (1954) Skleromyx\u00f6dem (eine eigenartige Erscheinungsform von Myxothesaurodermie). Arch Dermatol Syph 199:71\u201391","journal-title":"Arch Dermatol Syph"},{"key":"9379_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.sder.2006.04.001","volume":"25","author":"F Rongioletti","year":"2006","unstructured":"Rongioletti F (2006) Lichen myxedematosus (papular mucinosis): new concepts and perspectives for an old disease. Semin Cutan Med Surg 25:100\u2013104","journal-title":"Semin Cutan Med Surg"},{"key":"9379_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0190-9622(95)90007-1","volume":"33","author":"AM Dinneen","year":"1995","unstructured":"Dinneen AM, Dicken CH (1995) Scleromyxedema. J Am Acad Dermatol 33:37\u201343","journal-title":"J Am Acad Dermatol"},{"key":"9379_CR27","first-page":"208","volume":"153","author":"F Rongioletti","year":"2018","unstructured":"Rongioletti F, Ferreli C, Atzori L, Bottoni U, Soda G (2018) Scleroderma with an update about clinico-pathological correlation. G Ital Dermatol Venereol 153:208\u2013215","journal-title":"G Ital Dermatol Venereol"},{"key":"9379_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1067\/mjd.2001.111630","volume":"44","author":"F Rongioletti","year":"2001","unstructured":"Rongioletti F, Rebora A (2001) Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 44:273\u2013281","journal-title":"J Am Acad Dermatol"},{"key":"9379_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0190-9622(98)70567-5","volume":"38","author":"A Godby","year":"1998","unstructured":"Godby A, Bergstresser PR, Chaker B, Pandya AG (1998) Fatal scleromyxedema: report of a case and review of the literature. J Am Acad Dermatol 38:289\u2013294","journal-title":"J Am Acad Dermatol"},{"key":"9379_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1600-0560.2012.01882.x","volume":"39","author":"KE Fleming","year":"2012","unstructured":"Fleming KE, Virmani D, Sutton E, Langley R, Corbin J, Pasternak S et al (2012) Scleromyxedema and the dermato-neuro syndrome: case report and review of the literature. J Cutan Pathol 39:508\u2013517","journal-title":"J Cutan Pathol"},{"key":"9379_CR31","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jaad.2008.11.013","volume":"60","author":"JB Rey","year":"2009","unstructured":"Rey JB, Luria RB (2009) Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin. J Am Acad Dermatol 60:1037\u20131041","journal-title":"J Am Acad Dermatol"},{"key":"9379_CR32","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.7150\/ijbs.4666","volume":"8","author":"T Tanaka","year":"2012","unstructured":"Tanaka T, Kishimoto T (2012) Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int J Biol Sci 8:1227\u20131236","journal-title":"Int J Biol Sci"},{"key":"9379_CR33","first-page":"717808","volume":"2013","author":"M Yang","year":"2013","unstructured":"Yang M, Cen X, Xie Q, Zuo C, Shi G, Yin G (2013) Serum interleukin-6 expression level and its clinical significance in patients with dermatomyositis. Clin Dev Immunol 2013:717808","journal-title":"Clin Dev Immunol"},{"key":"9379_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1126\/science.622555","volume":"199","author":"RA Harper","year":"1978","unstructured":"Harper RA, Rispler J (1978) Lichen myxedematosus serum stimulates human skin fibroblast proliferation. Science 199:545\u2013547","journal-title":"Science"},{"key":"9379_CR35","first-page":"171","volume":"12","author":"M Yaron","year":"1985","unstructured":"Yaron M, Yaron I, Yust I, Brenner S (1985) Lichen myxedematosus (scleromyxedema) serum stimulates hyaluronic acid and prostaglandin E production by human fibroblasts. J Rheumatol 12:171\u2013175","journal-title":"J Rheumatol"},{"key":"9379_CR36","first-page":"747584","volume":"2014","author":"P Olczyk","year":"2014","unstructured":"Olczyk P, Mencner L, Komosinska-Vassev K (2014) The role of the extracellular matrix components in cutaneous wound healing. Biomed Res Int 2014:747584","journal-title":"Biomed Res Int"},{"key":"9379_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/glycob\/cwy058","volume":"29","author":"L Carmen","year":"2019","unstructured":"Carmen L, Maria V, Morales-Medina JC, Vallelunga A, Palmieri B, Iannitti T (2019) Role of proteoglycans and glycosaminoglycans in Duchenne muscular dystrophy. Glycobiology 29:110\u2013123","journal-title":"Glycobiology"},{"key":"9379_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jaad.2005.04.012","volume":"53","author":"A Kreuter","year":"2005","unstructured":"Kreuter A, Altmeyer P (2005) High-dose dexamethasone in scleromyxedema: report of 2 additional cases. J Am Acad Dermatol 53:739\u2013740","journal-title":"J Am Acad Dermatol"},{"key":"9379_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaad.2004.01.058","volume":"51","author":"JC Sansbury","year":"2004","unstructured":"Sansbury JC, Cocuroccia B, Jorizzo JL, Gubinelli E, Gisondi P, Girolomoni G (2004) Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. J Am Acad Dermatol 51:126\u2013131","journal-title":"J Am Acad Dermatol"},{"key":"9379_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1468-3083.2006.01814.x","volume":"21","author":"P Iranzo","year":"2007","unstructured":"Iranzo P, Lopez-Lerma I, Blade J, Rovira M, Herrero C (2007) Scleromyxoedema treated with autologous stem cell transplantation. J Eur Acad Dermatol Venereol 21:129\u2013130","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9379_CR41","first-page":"1071","volume":"137","author":"AM Feasel","year":"2001","unstructured":"Feasel AM, Donato ML, Duvic M (2001) Complete remission of scleromyxedema following autologous stem cell transplantation. Arch Dermatol 137:1071\u20131072","journal-title":"Arch Dermatol"},{"key":"9379_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ad.2011.04.015","volume":"103","author":"I Bielsa","year":"2012","unstructured":"Bielsa I, Benvenutti F, Guinovart RM, Ferrandiz C (2012) Good response of scleromyxedema and dermato-neuro syndrome to treatment with intravenous immunoglobulins. Actas Dermosifiliogr 103:317\u2013320","journal-title":"Actas Dermosifiliogr"},{"key":"9379_CR43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000353178","volume":"5","author":"M Allam","year":"2013","unstructured":"Allam M, Ghozzi M (2013) Scleromyxedema: a case report and review of the literature. Case Rep Dermatol 5:168\u2013175","journal-title":"Case Rep Dermatol"},{"key":"9379_CR44","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/j.leukres.2011.07.021","volume":"35","author":"M Migkou","year":"2011","unstructured":"Migkou M, Gkotzamanidou M, Terpos E, Dimopoulos MA, Kastritis E (2011) Response to bortezomib of a patient with scleromyxedema refractory to other therapies. Leuk Res 35:e209\u2013e211","journal-title":"Leuk Res"},{"key":"9379_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/MD.0b013e3181630835","volume":"87","author":"M Blum","year":"2008","unstructured":"Blum M, Wigley FM, Hummers LK (2008) Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG). Medicine (Baltimore) 87:10\u201320","journal-title":"Medicine (Baltimore)"},{"key":"9379_CR46","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1365-2133.2007.08169.x","volume":"157","author":"P Gholam","year":"2007","unstructured":"Gholam P, Hartmann M, Enk A (2007) Arndt-Gottron scleromyxoedema: successful therapy with intravenous immunoglobulins. Br J Dermatol. 157:1058\u20131060","journal-title":"Br J Dermatol."},{"key":"9379_CR47","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.annder.2010.08.011","volume":"137","author":"M Le Moigne","year":"2010","unstructured":"Le Moigne M, Mazereeuw-Hautier J, Bonnetblanc JM, Astudillo L, D'Incan M, Bessis D et al (2010) Caract\u00e9ristiques cliniques et \u00e9volutives du scl\u00e9romyxoedeme: \u00e9tude r\u00e9trospective multicentrique. Ann Dermatol Venereol 137:782\u2013788","journal-title":"Ann Dermatol Venereol"},{"key":"9379_CR48","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1600-0609.2012.01772.x","volume":"88","author":"J Canueto","year":"2012","unstructured":"Canueto J, Labrador J, Roman C, Santos-Briz A, Contreras T, Gutierrez NC et al (2012) The combination of bortezomib and dexamethasone is an efficient therapy for relapsed\/refractory scleromyxedema: a rare disease with new clinical insights. Eur J Haematol 88:450\u2013454","journal-title":"Eur J Haematol"},{"key":"9379_CR49","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1365-2133.2005.06710.x","volume":"153","author":"B Shergill","year":"2005","unstructured":"Shergill B, Orteu CH, McBride SR, Rustin MH (2005) Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin. Br J Dermatol 153:650\u2013652","journal-title":"Br J Dermatol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09379-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09379-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09379-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T23:04:44Z","timestamp":1589929484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09379-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["9379"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09379-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"11 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The case study has been report in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Informed consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}